Cargando…
Discovery of novel potential KIT inhibitors for the treatment of gastrointestinal stromal tumor
Numerous inhibitors of tyrosine-protein kinase KIT, a receptor tyrosine kinase, have been explored as a viable therapy for the treatment of gastrointestinal stromal tumor (GIST). However, drug resistance due to acquired mutations in KIT makes these drugs almost useless. The present study was designe...
Autores principales: | Jiang, Lili, Zhang, Zhongmin, Wang, Zhen, Liu, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020195/ https://www.ncbi.nlm.nih.gov/pubmed/33851030 http://dx.doi.org/10.1515/biol-2021-0036 |
Ejemplares similares
-
Discovery of a highly selective KIT kinase primary V559D mutant inhibitor for gastrointestinal stromal tumors (GISTs)
por: Yu, Kailin, et al.
Publicado: (2017) -
Frequent KIT Mutations in Human Gastrointestinal Stromal Tumors
por: Xu, Zhi, et al.
Publicado: (2014) -
Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumor
por: Katz, Steven C, et al.
Publicado: (2013) -
C-Kit-Negative Gastrointestinal Stromal Tumor in the Stomach
por: Seo, Ho Seok, et al.
Publicado: (2015) -
Discovery of novel heteroaryl alkynes for highly potent KIT(D816V) cells inhibition to treat gastrointestinal stromal tumors
por: Xie, Zhicheng, et al.
Publicado: (2022)